| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 2.00 | -0.20 (-9.09%) | 1.25 - 3.40 | 700.0 (Below Avg) |
Market data as of 10:01AM 06/18/13. Quotes are delayed by at least 15 min.
| Open | 2.00 |
|---|---|
| Previous Close | 2.20 |
| Day's Range | 2.00 - 2.00 |
| Market Cap | 44.8M |
| Avg Volume (10 Day) | 990.0 |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Neutral |
|---|---|
| Avoids excess debt? | Neutral |
| Converting sales to profits? | Neutral |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Neutral |
| Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Neutral |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Neutral |
| Stock is undervalued? | Neutral |
| Have investors caught on? | Neutral |
| Has support of institutional investors? | Neutral |
| Has sufficient liquidity? | Neutral |
DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
PR Newswire - Monday 06/10/2013 7:00 AM ET
NYSE and OTC Markets Companies Webcast Live to Investors on June 6th at RetailInvestorConferences.com
PR Newswire - Tuesday 06/04/2013 6:30 AM ET
DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
PR Newswire - Monday 06/03/2013 8:00 AM ET
DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 6th
PR Newswire - Friday 05/31/2013 7:00 AM ET
DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
PR Newswire - Tuesday 05/28/2013 8:00 AM ET
DelMar Pharmaceuticals To Present At The Second Annual Marcum LLP MicroCap Conference
PR Newswire - Monday 05/20/2013 8:00 AM ET
| DMPI | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -- | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | -- | |
| Price/Sales | -- |
| Company | Last | Change |
|---|
Data is delayed by at least 15 min.